麦默通微创旋切术附加小切口与传统手术切除乳房巨大良性肿瘤的比较  

Comparison of Mammotome Minimally Invasive Surgical Technique Plus Small Incision With Traditional Surgery for Giant Benign Tumor of Breast

作　　者：杨迎旭 田思齐 钱跃军 吕晶 董汉华 Yang Yingxu;Tian Siqi;Qian Yuejun(Department of Breast and Thyroid Surgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, China)

机构地区：[1]郑州大学附属郑州中心医院乳腺甲状腺外科,郑州450007 [2]郑州大学第三附属医院病理科,郑州450052

出　　处：《中国微创外科杂志》2019年第9期803-807,共5页Chinese Journal of Minimally Invasive Surgery

基　　金：河南省卫生厅医学科技攻关计划项目(201403266)

摘　　要：目的探讨麦默通微创旋切术附加小切口切除乳房巨大良性肿瘤的可行性与安全性。方法回顾性分析2015年1月~2018年1月我院64例乳房巨大良性肿瘤的临床资料,按照病例入院时间分为2组:麦默通组34例,传统手术组30例,比较2组手术切口长度、手术时间、术后并发症、术后切口瘢痕及术后乳房形态满意率等。结果麦默通组切口长度(1. 34±0. 15) cm,明显短于传统手术组(4. 22±0. 52) cm(t=-29. 261,P=0. 000);手术时间(23. 2±2. 7) min,稍短于传统手术组(25. 9±2. 1) min(t=-4. 439,P=0. 007)。2组术后皮肤瘀斑发生率分别为23. 5%(8/34)、20. 0%(6/30)),无统计学差异(χ^2=0. 116,P=0. 733);术后血肿发生率分别为14. 7%(5/34)、13. 3%(4/30),无统计学差异(χ^2=0. 000,P=1. 000);术腔积液发生率分别为8. 8%(3/34)、13. 3%(4/30),无统计学差异(χ^2=0. 031,P=0. 861)。2组患者中位随访9个月(6~12个月),麦默通组未见肿瘤残留,2组患者瘢痕明显率差异有统计学意义[8. 8%(3/34) vs. 80. 0%(24/30),χ^2=33. 105,P=0. 000];乳房形态满意率差异有统计学意义[94. 1%(32/34) vs. 66. 7%(20/30),χ^2=7. 883,P=0. 005]。结论麦默通微创旋切术附加小切口切除乳房巨大良性肿瘤微创、可行,值得临床推广应用。Objective To explore the feasibility and safety of Mammotome minimally invasive surgical technique plus small incision in the treatment of giant benign tumor of breast. Methods Clinical data of 64 patients with giant benign tumor of breast operated in our hospital from January 2015 to January 2018 were retrospectively analyzed. The patients were divided into either observation group with Mammotome minimally invasive technique plus small incision ( n =34) or the control group with traditional surgery ( n =30). The differences of the two group were compared in incision length, operation time,postoperative complications, scar and breast morphology satisfaction rate. Results As compared to the control group, the observation group had significant shorter incision length [(1.34±0.15) cm vs.(4.22±0.52) cm, t =-29.261, P =0.000], and shorter operation time [(23.2±2.7) min vs.(25.9±2.1) min, t =-4.439, P =0.000]. There were no significant differences between the observation group and the control group in skin ecchymosis [23.5%(8/34) vs. 20.0%(6/30),χ^2 =0.116, P =0.733], postoperative hematoma [14.7%(5/34) vs. 13.3%(4/30),χ^2 =0.000, P =1.000], and postoperative cavity effusion [8.8%(3/34) vs. 13.3%(4/30),χ^2 =0.031, P =0.861]. All the patients were followed up.Residual tumor was not found in the observation group. The scar rate of the observation group was significant lower than that of the control group [8.8%(3/34) vs. 80.0%(24/30),χ^2 =33.105, P =0.000]. The breast morphology satisfaction rate of the observation group was significant better than that of the control group [94.1%(32/34) vs. 66.7%(20/30),χ^2 =7.883, P =0.005]. Conclusion It is feasible and effective that using Mammotome minimally invasive surgical technique plus small incision to cut off the giant benign tumor of breast.

关 键 词：纤维腺瘤 麦默通 

分 类 号：R737.9[医药卫生—肿瘤]